⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19087212 | 0.74 | — | — | |
| SCHEMBL15299167 | 0.73 | — | — | |
| SCHEMBL23570308 | 0.70 | — | — | |
| SCHEMBL10187264 | 0.70 | — | — | |
| SCHEMBL20442702 | 0.67 | — | — | |
| SCHEMBL16162254 | 0.66 | — | — | |
| SCHEMBL16121184 | 0.66 | — | — | |
| SCHEMBL21417562 | 0.66 | — | — | |
| SCHEMBL16162253 | 0.66 | — | — | |
| SCHEMBL17935602 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012001107-A1 | PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-01-05 | — | — | WO | disclosed |